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One Sentence Summary:  Quantitative SRS microscopy can detect human brain tumor 
infiltration with high sensitivity and specificity, even in tissues appearing grossly normal. 
 
 
 
ABSTRACT 
Differentiating tumor from normal brain is a major barrier to achieving optimal outcome in brain 
tumor surgery. New imaging techniques for visualizing tumor margins during surgery are needed 
to improve surgical results. We recently demonstrated the ability of stimulated Raman scattering 
(SRS) microscopy, a non-destructive, label-free optical method, to reveal glioma infiltration in 
animal models. Here we show that SRS reveals human brain tumor infiltration in fresh, 
unprocessed surgical specimens from 22 neurosurgical patients. SRS detects tumor infiltration in 
near-perfect agreement with standard hematoxylin and eosin light microscopy (κ=0.86). The 
unique chemical contrast specific to SRS microscopy enables tumor detection by revealing 
quantifiable alterations in tissue cellularity, axonal density and protein:lipid ratio in tumor-
infiltrated tissues. To ensure that SRS microscopic data can be easily used in brain tumor surgery, 
without the need for expert interpretation, we created a classifier based on cellularity, axonal 
density and protein:lipid ratio in SRS images capable of detecting tumor infiltration with 97.5% 
sensitivity and 98.5% specificity. Importantly, quantitative SRS microscopy detects the spread of 
tumor cells, even in brain tissue surrounding a tumor that appears grossly normal. By accurately 
revealing tumor infiltration, quantitative SRS microscopy holds potential for improving the 
accuracy of brain tumor surgery. 
 
INTRODUCTION 
Extent of resection, the percentage of tumor removed during surgery, is an important prognostic 
factor for brain tumor patients (1). Safely maximizing the extent of resection—removing 
cancerous regions while sparing healthy brain—remains a challenge, in part due to the difficulty 
of differentiating tumor from normal tissue (2). Consequently, suboptimal surgical outcomes are 
common for brain tumor patients (3). Various approaches have been developed to improve 
accuracy. For example, frameless stereotactic navigational systems correlate the position of an 
instrument within the surgical field to a virtual location in preoperatively obtained cross-
sectional (CT or MRI) image data. Frameless stereotaxy is invaluable for surgical planning and 
is therefore used ubiquitously for brain tumor surgery, but its effect on surgical outcome has 
been questioned (4, 5).   
The primary limitation of frameless stereotactic navigation is its reliance on preoperative 
imaging data, which becomes progressively less accurate as tissues shift during surgery. The 
shift of soft tissues within the skull, sometimes by more than 1 cm, is most profound during 
resection of large tumors (5). To address this limitation, intraoperative imaging systems, such as 
intraoperative MRI, were designed to provide updated navigational information during surgery 
(6) and have been shown to improve surgical outcomes in gliomas (7). However, adoption of 
intraoperative MRI has been limited owing to its high cost (>$10M) (8), an increase in surgical 
duration (9), and limited evidence demonstrating a survival benefit (10).  
Fluorescence-guided surgery using orally administered 5-aminolevulinic acid has been 
shown to improve extent of resection in high-grade glioma surgeries (11) but cannot easily be 
applied to low-grade tumors (12), has low sensitivity for tumor detection (13), and has not been 
approved by the U.S. Food and Drug Administration. Electrophysiological mapping of cortical 
and subcortical structures improves the safety and accuracy of brain tumor surgery by providing 
localization of key structures to avoid (14) but does not reveal the margin between tumor-
infiltrated and non-infiltrated brain. 
Stimulated Raman scattering (SRS) microscopy is a rapid, non-destructive, label-free 
technique that has recently been proposed to guide the surgical removal of brain tumors (15). 
Like spontaneous Raman scattering, SRS microscopy relies solely on the vibrational properties 
and distribution of macromolecular components such as lipids, proteins, and DNA to generate 
chemical contrast (16). Importantly, Raman spectroscopic properties of brain tissue are altered 
by infiltrating tumor cells and can be detected during surgery (17). In contrast to spontaneous 
Raman scattering, the coherent nature of signal generation in SRS microscopy is highly sensitive, 
allowing for rapid microscopic imaging, even in reflectance mode (18). Consequently, SRS 
microscopy holds promise for in vivo application because of its ability to generate microscopic 
images in situ without removing or processing the tissue. We have previously reported the ability 
of SRS microscopy to qualitatively delineate brain tumor margins in animal models of glioma in 
vivo and to reveal cytoarchitectural features of human glioblastoma (15). 
Here we evaluate the ability of quantitative SRS microscopy to detect brain tumor 
infiltration in tissue samples from 22 neurosurgical patients. We demonstrate that SRS 
microscopy reveals both normal cytoarchitectural features of the human brain and the pathologic 
hallmarks of brain tumors in a manner that can be quantified in an automated fashion. Using 
quantitative measurements of tissue cellularity, axonal density and protein:lipid ratio in SRS 
images, we derive a classifier capable of detecting tumor infiltration with excellent sensitivity 
and specificity, even in tissues that would appear normal during surgery. 
 
RESULTS 
SRS microscopy of structurally normal human brain tissue 
We used a two-color SRS microscopy method for imaging human tissues that has been 
previously described (19). In this method a Stokes beam (1064 nm) is combined with a tunable 
pump beam (650-1000 nm) from an optical parametric oscillator and they are focused on the 
sample via a laser scanning microscope. The energy difference between the pump and Stokes 
beams can be tuned to specific molecular vibrations, which cause an intensity loss in the pump 
beam, detectable with the aid of a lock-in amplifier (Fig. 1A). The Raman spectral differences 
between cortex, tumor, and white matter (Fig. 1B) reflect variations in the lipid:protein ratio, 
which can be used to generate contrast in microscopic images.  
We collected SRS images at two Raman frequencies (2845 and 2930 cm-1) for each 
300x300 µm2 field of view (FOV), and extracted the signals of lipid and protein based on their 
Raman intensity ratios at the two frequencies in normal human brain tissue. The protein signal 
was assigned to a blue channel, the lipid signal to a green channel. Consequently, lipid-rich 
structures, such as white matter, appeared green, whereas protein-rich structures, such as nuclei, 
appeared blue (Fig. 1C).  
To assess the ability of SRS microscopy to reveal the normal histoarchitecture of the 
human brain, we imaged 712 FOV from 14 biopsies obtained from three patients undergoing 
anterior temporal lobectomy for intractable epilepsy (patients 1-3). Notably, the cortical and 
subcortical tissue in patients undergoing anterior temporal lobectomy has been shown to be 
histoarchitecturally normal (20). At high magnification, the soma of neurons appeared as protein-
rich triangular structures with lipid-rich lipofuscin inclusions (Fig. 1C). Linear, lipid-rich axons 
in white matter (Fig. 1D), bundles of axons forming tracts at the gray-white junction (Fig. 1E), 
and capillaries filled with protein-rich erythrocytes were also visible (Fig. 1F). The high 2930 
cm-1 signal characteristic of cells and the extracellular matrix of the cortex contrasts with the 
high 2845 cm-1 signal characteristic of lipid-rich, myelinated axons in white matter to provide a 
means for visually differentiating gray from white matter (Fig. 1G).  
 
SRS microscopy of CNS malignancies 
We then imaged 39 biopsies from 19 patients with CNS tumors (table S1) to compare SRS and 
H&E microscopy. In glioblastoma tissue from Patient 19 (Fig. 2A), SRS microscopy revealed 
hypercellularity (Fig. 2B, left), microvascular proliferation (Fig. 2C, left), and mitotic activity 
(Fig. 2D, left). Low-grade oligodendroglioma tissue from Patient 22 (Fig. 2E) was characterized 
by distinctive cells with round nuclei and protein-rich cytoplasm (Fig. 2F), delicate capillaries 
(Fig. 2G), and perineuronal satellitosis (Fig. 2H). The pediatric medulloblastoma in Patient 6 was 
distinguished by abundant small round cells, which may be organized into pseudorosettes and 
often demonstrate apoptosis and brisk mitotic activity (fig. S1). In Patient 13, radiation-induced 
change in previously treated tumor was evident (fig. S2). We included both densely (Fig 2) and 
minimally hypercellular (fig. S3) gliomas in our series to demonstrate the ability of SRS 
microscopy to detect characteristic histopathologic changes with low levels of tumor infiltration.  
SRS imaging also revealed diagnostic features of extrinsic CNS tumors. The 
cytoarchitecture of meningioma in Patient 7 demonstrated densely packed tumor cells organized 
in a fascicular pattern with whorling and calcification (fig. S4, A to D). SRS imaging of 
metastatic non-small cell lung carcinoma in Patient 8 showed anaplastic round cells with little 
extracellular material, multinucleated tumor cells, and necrotic regions (fig. S4, E to H). SRS 
images of spinal schwannoma from Patient 9 revealed a sheet-like arrangement of cells with 
fusiform nuclei and occasional prominent nucleoli, as well as hemosiderin-laden CD68+ 
macrophages (fig. S5). 
Infiltrating glioma cells adjacent to the tumor core are of particular clinical significance 
because they are thought to give rise to recurrence in approximately 90% of cases (21). Given 
the limited spatial resolution of clinical MRI and ultrasound systems, intraoperative detection of 
infiltrating glioma cells is not currently possible. In contrast, because SRS microscopy reveals 
the cytoarchitecture of both normal brain and tumors, it can be used to image tumor margins. For 
example, a gradual decrease in cellularity at the margins of both high-grade (Fig. 3A) and low-
grade (Fig. 3B) gliomas was well demonstrated by SRS imaging.  
 
Correlation between SRS and H&E microscopy for tumor detection 
We then tested the hypothesis that SRS imaging can detect tumor with comparable performance 
to H&E microscopy of formalin-fixed tissue. We presented neuropathologists with a web-based 
survey of 75 SRS images and 75 similar H&E 300x300 µm2 FOVs from 7 patients (3 “normal” 
controls from epilepsy patients [patients 1-3], 2 low-grade glioma patients [patients11,18]  and 2 
high-grade glioma patients [patients 19, 22]) and asked them to classify the images into three 
categories—normal to minimally hypercellular tissue, infiltrating glioma, or dense glioma—
based on the degree of tumor infiltration. The survey demonstrates near-perfect agreement 
between SRS and H&E imaging (κ>0.86) for detecting the presence of tumor infiltration (Table 
1). There was also near-perfect agreement (κ>0.81) between methods for detecting the degree of 
infiltration.  
The most frequent errors in both H&E (13 errors) and SRS (8 errors) FOVs occurred in 
classification of infiltrating glioma. We hypothesize that the H&E errors are due to the subjective 
nature of histopathologic interpretation and the limited size of the FOVs presented. The presence 
of nuclear atypia can be discerned in infiltrating glioma cells on H&E. However, these features 
are somewhat less clear with SRS, which could explain the errors within this category.  
 
SRS microscopic images can be quantified based on histoarchitecture 
Interpretation of histopathologic findings requires the expertise of a pathologist, has a subjective 
component, and may be time-intensive. Automated methods have been shown to detect 
histopathologic features in human malignancies (22, 23). To ensure that SRS imaging data can 
be smoothly incorporated into the existing operative workflow, we sought to develop an 
automated means of detecting tumor infiltration. The ideal classification scheme would integrate 
robust, quantified SRS image attributes (hypercellularity, axonal density, protein:lipid ratio) into 
a single metric for detecting infiltration.  
To quantify the salient histologic features in SRS datasets, we developed a program 
capable of automatically quantifying the number of nuclei, axonal density and protein:lipid ratio 
in each FOV (fig. S6). The automated cell-counting and axonal quantification program correlated 
well with manual methods for distinguishing normal brain from, infiltrating and dense glioma 
(Fig 4A, fig S6), though some discrepancies in cell counts occurred where nuclear contrast was 
faint or obscured (table S2). We verified our image quantification methods by evaluating 
adjacent FOVs at key transitions in our specimens: the gray-white junction (fig. S7) and the 
margins of an oligodendroglioma (Fig 4B). The cellularity and protein:lipid ratios decreased with 
an accompanying increase in axonal density moving from cortex into white matter (fig. S7). A 
similar pattern existed moving from within a tumor into adjacent brain, but the difference in 
cellularity was approximately an order of magnitude greater (Fig 4B).  
We then quantified and plotted cellularity, axonal density, and protein:lipid ratio of 1477 
300x300 µm2 FOVs from 51 fresh tissue biopsies from 18 patients (3 epilepsy patients, 15 brain 
and spine tumors encompassing 8 distinct histologic subtypes). The three-dimensional plots of 
averaged values for each of the 51 biopsies (Fig. 5A) revealed the variability in each attribute 
among the tissues analyzed. A plot of each of the 1477 FOV revealed a gradient of the 
parameters distinguishing normal from densely tumor-infiltrated tissue (fig. S8)  
 
Detection of tumor infiltration using quantitative SRS microscopy 
The individual tissue attributes had varying degrees of sensitivity and specificity to indicate 
tumor infiltration (table S3).  However, to create a robust classifier for predicting tumor 
infiltration incorporating each tissue attribute, we used a quasi-likelihood approach with a 
generalized additive model (GAM) (24). The classifier was built from 1477 FOVs derived from 
three patients with temporal lobe epilepsy and 15 brain tumor patients. Half of the FOVs (n=738) 
were used to create the classifier, which was then tested on the other half (n=739). Classifier 
values ranged from 0 to 1, where 0 carried the lowest probability of tumor infiltration and 1 
carried the highest probability of infiltration. The classifier distinguished between tumor-
infiltrated and non-tumor-infiltrated brain with a mean sensitivity of 97.5% and specificity 
98.5% (AUC 0.995) (Table 2).  The classifier also distinguished between categories of tumor 
infiltration (normal to minimal hypercellularity, infiltrating glioma, dense glioma) with a high 
degree of accuracy regardless of grade or histologic subtype (Fig. 5, B and C).  We also verified 
that the classifier was in close agreement to the pathologists’ determination of tumor infiltration 
(table S4). 
The classifier was created from an array of tumors encountered in and near the central 
nervous system (table S1) so that it could be broadly generalizable. However, because glial 
tumors are more infiltrative and have less distinct margins than non-glial tumors, discriminating 
glial tumor infiltration from non-infiltrated brain poses the greatest challenge. We therefore 
created a separate quasi-likelihood GAM, including only glial tumors and controls. The glioma-
only GAM distinguished between tumor-infiltrated and non-infiltrated brain with 97.0% 
sensitivity and 98.7% specificity (Table 2).  
Although the quasi-likelihood GAM classifier accounts for within-subject correlation and 
the training sets are not included in building the classifier, it is still possible that some of the 
testing set data are correlated with some of the training set data (e.g. they come from the same 
subject).  To break this dependence, we used a leave-one-out cross-validation approach (25) on 
the dataset consisting of exclusively glial tumors (and epilepsy patients as controls). Though not 
as accurate as the quasi-likelihood GAM, the leave-one-out cross-validation approach yielded 
87.3% sensitivity and 87.5% specificity (Table 2).  
 
SRS imaging indicates microscopic tumor infiltration beyond gross margins 
Infiltrating brain tumor cells spread beyond the gross (26) and radiographic (27) margins of the 
tumor. To evaluate the ability of SRS imaging to detect microscopic infiltration within and 
around a brain tumor, we used a cadaveric specimen from a newly diagnosed glioblastoma 
patient who expired shortly after diagnosis, prior to treatment.  A 1-cm thick coronal section of 
the patient’s brain was serially sampled (Fig. 6A).  
Specimens from within the necrotic core, at the viable tumor margin, and at 5-mm 
intervals from the gross tumor margin were evaluated for tumor infiltration with SRS, H&E 
microscopy, and immunohistochemistry. The biopsy from viable, dense tumor demonstrated 
hypercellularity and nearly complete obliteration of the neuropil (NF), with diffuse expression of 
EGFR (Fig. 6B, left). The biopsy (Fig. 6B, middle) taken from 5 mm outside of the gross margin 
demonstrated moderate hypercellularity with partial preservation of axonal architecture (NF) and 
focal expression of EGFR, consistent with infiltrating tumor. The biopsy taken 15 mm from the 
apparent margin demonstrated normal cellularity and axonal density (NF) without evidence of 
EGFR expression (Fig. 6B, right). Quantification of 295 FOVs from the cadaveric specimens 
demonstrated decreasing protein:lipid ratio and cellularity, and increasing axonal density with 
increasing distance from the tumor (Fig. 6C). Notably, the quasi-likelihood GAM classifier 
accurately predicted tumor infiltration in specimens sampled up to 10 mm from the gross margin. 
  
DISCUSSION 
In brain tumor patients, residual tumor often gives rise to recurrence and ultimately treatment 
failure(1)(28). Therefore, ensuring maximal resection, while preserving neurologic function, is 
the guiding principle of brain tumor surgery. However, surgeons lack an effective means for 
ensuring optimal surgical results, leaving removable tumor in the operative cavity in up to 83% 
of glioma resections (29). Suboptimal tumor removal occurs because surgeons must balance 
tumor removal with preservation of neurologic function, and due to difficulty visualizing tumor 
during surgery (3).  
Here, we demonstrate how SRS imaging could be used to detect occult tumor by 
revealing microscopic cancer infiltration in surgical specimens. SRS microscopy reveals axons 
and cells, making quantification of histoarchitectural structures feasible. Quantitative SRS 
imaging creates an automated, mathematical means of predicting the likelihood of tumor 
infiltration in a given specimen, reducing reliance on interpretation of histopathologic data .  
Importantly, our data suggest that SRS imaging can detect infiltration outside of the gross 
margins of a glioma, where it would be undetectable to the surgeon.  
Confocal fluorescence microscopy and photoacoustic imaging have also been explored 
for microscopic guidance in brain tumor surgery (30, 31). However, these methods rely upon the 
uptake of dyes, which are unevenly distributed within tumors (32, 33) and do not allow direct 
visualization of normal brain tissue that should be preserved. Consequently, label-free techniques 
have also been proposed. Notably, spontaneous Raman spectroscopy has been successfully 
applied to the intraoperative detection of tumor infiltration. However, to acquire spontaneous 
Raman spectra during surgery, ambient lighting must be eliminated and custom lighting would 
be needed (17). In addition, spontaneous Raman spectroscopy lacks the spatial resolution of SRS 
microscopy and relies exclusively on spectroscopic analysis for tumor detection. Optical 
coherence tomography (34), confocal reflection (35), and third harmonic generation (36), reveal 
some morphologic features of brain tissue but lack the chemical contrast that helps to distinguish 
tumor-infiltrated and non-infiltrated brain. SRS microscopy is unique because it achieves high 
sensitivity and specificity for detecting brain tumor infiltration by combining chemical 
specificity (protein:lipid ratio) and high-resolution morphological information (cellularity and 
axonal density).  
Prior to the demonstration of SRS in 2008 (16), coherent anti-Stokes Raman scattering 
(CARS) microscopy was proposed for brain tumor imaging (37) because of its ability to detect 
tumor infiltration based on alterations in the CH range of the Raman spectrum and tissue 
architecture in glioma models (38). SRS was later shown to have superior nuclear contrast in 
comparison to CARS (19). Background signals in SRS microscopy (39),such as cross-phase 
modulation, and thermal effects are much weaker than the CH region SRS signals and do not 
degrade image quality. Importantly, combined with lock-in detection, SRS imaging can be 
carried out under standard ambient-lighting conditions. A broadband CARS method 
incorporating the fingerprint region of the Raman spectrum promises to further increase the 
chemical specificity of the technique (40). In this report, we have chosen to focus on high-speed 
imaging based on narrowband SRS and strong CH region signal to ensure rapid acquisition of 
high-resolution microscopic images.  
Freudiger et al. developed a robust, tunable, ultra-fast, dual-wavelength, all-fiber laser 
system based on the optical synchronization of two picosecond power amplifiers for coherent 
Raman scattering microscopy (41). Importantly, unlike solid-state lasers, the fiber laser system is 
well suited for clinical use since it requires neither an optical table nor a climate control system 
and maintains stability under mechanical manipulation and long-term use. With noise correction, 
the fiber laser can produce SRS image quality comparable to that of a solid-state laser.  
This study focused on ex vivo evaluation of SRS microscopy as a supplement to standard 
pathology. Future work will determine whether clinical SRS imaging is best achieved on 
specimens ex vivo or within a surgical cavity in vivo. Ex vivo SRS imaging can, in theory, be 
accomplished with an optical instrument that is free of the size restrictions of a handheld probe, 
the safety concerns of exposing the brain to laser irradiation, and the challenges of imaging tissue 
within the dynamic surgical environment. Nonetheless, we previously demonstrated that in vivo 
SRS imaging is feasible in simulated surgical conditions (15). If successful, in vivo SRS imaging 
would create the possibility of imaging tissue that could not be safely removed.  
Incorporating SRS microscopy into the neurosurgical workflow is essential for clinical 
translation. Widespread use of navigational systems for brain tumor surgery creates an 
opportunity to integrate and display microscopic data in the context of the operative field (31). 
We postulate that SRS microscopic images will be most useful if they are co-registered to the 
MRIs used for navigation. Co-registration is feasible whether SRS microscopy is carried out ex 
vivo using a slide scanner or in situ via a tracked handheld probe (figs. S9 and S10).   
Like any microscopic imaging modality, SRS microscopy generates FOVs much smaller 
than a typical tumor cavity. Consequently, developing a protocol ensuring representative 
imaging of a tumor cavity is essential. Sampling protocols for frozen section assessment of 
tumor margins in head and neck (42) and breast cancer (43) operations could be used to inform a 
protocol for brain tumor sampling. SRS microscopy could also be of value in squamous cell 
carcinomas of the head and neck, where the proximity of cancer cells to the resection margin is a 
major prognostic factor (44). Notably, SRS microscopy can only image at a maximal depth of 
penetration of approximately 100 µm in biological tissues. Consequently, detecting residual 
tumor deeper than 100 µm would not be possible unless the tissue in question was surgically 
exposed.  
In summary, we demonstrate the potential of SRS microscopy to image and detect tumor 
infiltration in the human brain. Our data provide strong justification for development of clinical 
SRS microscopes that interface with existing navigational systems. By enhancing standard 
navigational data with intraoperative histologic data, label-free SRS microscopy holds potential 
to improve the accuracy and safety of brain tumor surgery. 
 
MATERIALS AND METHODS 
Study design 
The inclusion criteria for this study were: (1) males and females, (2) subjects scheduled for brain 
tumor resection at the University of Michigan Health System, (3) subjects willing to give 
informed consent or have an authorized representative consent on their behalf, and (5) subjects in 
which there was excess tumor tissue beyond what was needed for diagnosis. The sample size was 
estimated at 20 patients to ensure a diverse array of tumors could be imaged for analysis and 
based on the design of prior studies comparing SRS and H&E. The central goals of this study 
were twofold. First, we sought to evaluate the ability of SRS microscopy to image glioma 
infiltration. Second, we aimed to assess the predictive power of image features of SRS 
micrographs in differentiating tumor from normal tissue. We began by collecting biopsies 
(N=60) from neurosurgical patients undergoing tumor resection (n=19) or anterior temporal 
lobectomy (n=3). Half of each biopsy was formalin-fixed, paraffin-embedded, and H&E stained, 
while the other half was imaged fresh with SRS microscopy. A trained neuropathologist (S.C.P) 
then classified each biopsy as normal to minimally hypercellular, infiltrating tumor, or dense 
tumor. We then quantified the correlation between SRS and H&E tissue imaging of glioma 
through a blinded web-based survey administered to neuropathologists (S.R., M.S., S.V.).  
To quantify the SRS images, we developed and implemented an image segmentation 
program using MATLAB software (The MathWorks, Inc.), which segmented and quantified 
nuclei and axons in SRS images. We verified that manual and automated cell counts and axonal 
density were consistent in the quantified specimens. Specimens from 3 patients (patients 4, 5, 9) 
were excluded from quantitative analysis on this basis. Specimens from patient 21 were excluded 
because they were predominantly necrotic. Using samples from the remaining 18 patients, we 
constructed a GAM with a logistic link, which was used to build a classifier capable of 
predicting the probability that a given FOV contained tumor. To break the dependence inherent 
in the GAM classifier, we verified the classifier performance with leave one out cross validation. 
 
SRS microscopy 
Detailed setup of the SRS microscope has been described previously (16). The pulsed Stokes 
(1064 nm) and pump beams (690-990 nm) were directed from an integrated one-box optical 
parametric oscillator (picoEmerald; Applied Physics & Electronics; 7 ps, 80 MHz), overlapped 
spatially and temporally, coupled into a laser-scanning microscope (FV300; Olympus Corp.), 
and focused into the sample (Fig. 1A). SRS images were collected in transmission mode at 1 
frame/sec throughout the study. Specific Raman frequency was selected by tuning the frequency 
difference between the pump and Stokes beams. Since SRS microscopy is a self-heterodyning 
process, we used a modulation-demodulation method to detect the signal. We modulated the 
Stokes intensity at a high frequency (10 MHz) with an electro-optical modulator (EOM), and 
detected the weak SRS signal over the large pump intensity (ΔI/I < 10-4) using a fast home-built 
demodulator (18). To image large areas of tissues, automated tiling and stitching were realized 
using software to synchronize the wavelength tuning and sample stage motion. 
 
Survey methodology 
A web-based survey for pathologists was created by randomly selecting SRS and corresponding 
H&E FOVs from six patients, as described in Supplementary methods.  
 
Image segmentation 
SRS microscopy images were segmented and analyzed as described in Supplementary methods.  
 
Fresh human brain tumor specimen imaging 
Sixty fresh tissue biopsies were procured from 19 patients undergoing brain tumor resection and 
3 patients undergoing anterior temporal lobectomy for intractable epilepsy at the University of 
Michigan Health System through Institutional Review Board (IRB) protocol (#HUM00083059) 
yielding 1684 FOV. All patients were informed of the risks of participating in the study during 
the consent process. A portion of the tissue, in excess of what was needed for histopathologic 
diagnosis, was allocated for SRS imaging during surgery. Tissue was treated as described in 
Supplementary methods.  
 
Statistical methods for generating the classifier 
Data are taken from multiple FOVs from individual biopsies. Thus the data are correlated and 
standard statistical models that assume the data are independent do not apply.  Quasi-likelihoods 
methods (46), however, include a dispersion parameter that accounts for over- or under-
dispersion in the data caused by correlation within subjects and, thus, are valid statistical 
methods for clustered data (e.g. FOVs within individuals). A dispersion parameter greater than 1 
indicates over-dispersion and less than 1 indicates under-dispersion. We adopted a quasi-
likelihood approach to build our classifiers; in particular, a quasi-binomial approach. In our 
classifiers, the covariates enter the quasi-likelihood using a GAM approach (24) as opposed to 
entering linearly. This allows more flexibility in modeling the decision boundary between groups. 
In the quasi-likelihood GAM method, the covariates enter as cubic spline functions. The 
covariates of interest are axonal density, nuclear density, protein:lipid ratio, and all two-way 
interactions between these covariates. 
We built four separate quasi-likelihood GAM classifiers: 1) normal vs. infiltrating plus 
dense tumor, 2) normal vs. infiltrating tumor, and 3) normal vs. dense tumor. We then used 
stepwise regression to determine the best fit to each of the three cases. Two-way interactions 
were taken prior to fitting the GAM with a cubic spline function. Stepwise regression selected 
the following covariates for each of the models: 1) the three main effects and the two-way 
interactions between axonal and nuclear densities and axonal density and the protein:lipid ratio, 
2) the three main effects and all three two-way interactions, 3) the three main effects and the 
interaction between axonal and nuclear densities, and 4) the three main effects and the 
interactions between axonal and nuclear densities and between nuclear densities and the 
protein:lipid ratio. 
Given the model determined by stepwise regression, we randomly split the data into two 
equal parts, creating a training set and a testing set. The quasi-likelihood GAM was refit to the 
training set and predictions were obtained from the testing set. Receiver operating characteristic 
curves, sensitivity, specificity, and accuracy were obtained using a discriminant probability 
threshold of 0.5 on the predictions made from the testing set. We performed the above analysis 
1000 times and reported the average and 95% confidence interval of these statistics over the 
1000 runs. 
To eliminate any possible correlation of data within the quasi-likelihood approach, we 
utilized the cross-validation approach described by Picard et al. (25). In this approach, a subject 
is left out of the training set. After the model is fitted to the training data, the left-out subject’s 
data are predicted using the model.  We re-ran the above four analyses using the cross validation 
approach each time leaving out a different subject. The leave-one-out cross validation was 
performed on the dataset that excluded patients with non-glial tumors. 
 
SUPPLEMENTARY MATERIALS 
Methods 
Fig. S1. SRS microscopy of pediatric medulloblastoma. 
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FIGURE LEGENDS 
Fig. 1.  SRS microscopy workflow and imaging of normal gray and white matter. All 
imaged specimens were collected from patients undergoing anterior temporal lobectomy for 
intractable epilepsy. (A) Experimental setup of SRS microscopy. The Stokes beam was 
modulated at high frequency (10 MHz), and the weak stimulated Raman loss signal was 
demodulated by a lock-in amplifier. A transmission mode detection scheme was used for ex vivo 
imaging on fresh tissues. DC, dichroic mirror; EOM, electro-optical modulator; FL, optical filter; 
GM, galvanometer mirror. (B) Raman spectra from fresh sections of human glioblastoma biopsy 
show white matter, cortex, and tumor. The marked frequencies (dashed lines) at 2845 and 2930 
cm-1 were chosen for two-color SRS imaging. (C) SRS imaging of normal gray matter at high 
magnification showing neuronal soma with pyramidal architecture filled with lipofuscin-rich 
granules (left), that stain positively for the neuronal nuclei antigen (NeuN) within the neuronal 
cell body (right). (D) SRS imaging of white matter (left) demonstrates individual axons 
appearing as linear, lipid-rich structures that correspond well with neurofilament 
immunohistochemical staining (right). (E) An SRS image of the gray-white junction (left) 
demonstrates parallel bundles of lipid-rich white matter tracts that are not visible with H&E 
staining (right). (F) Capillaries filled with protein-rich erythrocytes appear blue on SRS imaging 
(left) and eosinophilic on H&E-stained section (right). (G) At low magnification, the 
biochemical differences between protein-rich gray matter (blue) and myelinated white matter 
(green) are apparent.  
 
Fig. 2.  SRS and traditional microscopy of intrinsic brain tumors. (A) SRS imaging of a 
GBM (arrowhead) demonstrating ring enhancement on MRI. (B) Hypercellularity and nuclear 
atypia of viable tumor is apparent on both SRS (left) and H&E (right) microscopy. (C) 
Microvascular proliferation creates tortuous vascular complexes evident on SRS microscopy (left, 
arrowheads) and highlighted with periodic acid Schiff staining (right, arrowhead). (D) Mitotic 
figures are also visible (arrowheads) with SRS microscopy (left) and H&E staining (right). (E 
and F) A non-enhancing, low-grade oligodendroglioma (arrowhead, E) consists of hypercellular 
tissue with nests of “fried-egg” morphology (arrowheads, F) causing minimal axonal disruption 
on SRS imaging (left), as confirmed through neurofilament immunostaining (right). (G and H) 
“Chicken wire” blood vessels (arrowheads, G) imaged with SRS (left) and H&E (right) 
microscopy, and perineuronal satellitosis is visible in both SRS (left) and H&E (right) 
microscopy (H).  
 
Fig. 3.  SRS microscopy of tissue at the periphery of high- and low-grade gliomas. (A) SRS 
images of the margin of an infiltrating glioblastoma within cortex depicting a transition from 
densely tumor-infiltrated brain to minimally infiltrated brain (left to right). (B to D) Cellularity 
and protein:lipid ratio vary in high-magnification images acquired in densely infiltrated tissue 
(B), moderately infiltrated tissue (C), and minimally infiltrated tissue (D). (E) SRS imaging of an 
oligodendroglioma infiltrating within white matter, depicting a transition from densely tumor-
infiltrated brain to minimally infiltrated brain (left to right). (F to H) Variation in axonal density, 
cellularity, and protein:lipid ratio is apparent when comparing high-magnification images from 
densely infiltrated tissue (F), moderately infiltrated tissue (G), and minimally infiltrated tissue 
(H). 
 
Fig. 4.  Quantitative analysis of an infiltrative tumor margin imaged with SRS microscopy. 
(A) Cellularity was quantified manually and with automated methods in 20 representative fields 
of view, drawn from 6 patients with varying degrees of tumor infiltration (2 controls without 
tumor infiltration, 2 with infiltrating tumor and 2 with dense tumor infiltration). Data are 
averages ± SEM (B) The variability in cellularity, axonal density, protein:lipid raio, and 
classifier values at a brain tumor margin. SRS microscopy lipid and protein channels were 
overlaid. Heat maps show calculated axon densities (arbitrary units) for all FOVs, nuclei per 
FOV, calculated protein:lipid ratio for all FOVs, and classifier values for all FOVs. Insets are 
FOVs with high (red), average (yellow), and low (blue) classifier values.  
  
Fig. 5.  Nuclear density, axonal density and protein:lipid ratio are quantified from SRS 
images.  (A) Measurements were taken from 1477 300x300 µm2 FOVs from 51 fresh tissue 
biopsies from 18 patients (3 epilepsy patients, 15 brain and spine tumors encompassing 8 distinct 
histologic subtypes). Each point on the scatterplot represents the average value of each biopsy. 
Biopsies were classified as predominantly normal to minimally hypercellular (n = 21), 
infiltrating tumor (n=14), or high-density tumor (n = 16) by a board-certified neuropathologist 
based on H&E staining. Marker color indicates the mean classifier value for each biopsy, with 0 
(most likely normal) depicted in cyan and 1 (most likely tumor) depicted in red. Representative 
FOVs from normal cortex, normal white matter, low-grade glioma, and high-grade glioma are 
shown. (B and C) Relationship of classifier values with tumor density (B) and histologic subtype 
(C). All parameters are normalized to the maximum measurement obtained of that variable and 
displayed in arbitrary units. Data are means ± SEM.  
 
Fig. 6.  SRS microscopy within and surrounding a glioblastoma. (A) A coronal slice of 
cadaveric brain from a patient who expired with glioblastoma was sampled at the points 
indicated in green, shown along 5-mm iso-distance lines (as measured from the tumor margin). 
(B) FOVs captured from the gross tumor margin (0 mm), 5 mm outside the tumor margin 
(center), and 15 mm outside the tumor margin reveal dense tumor, infiltrating tumor, and normal 
tissue by SRS, H&E staining, EGFR immunohistochemistry, and neurofilament immunostaining. 
Scale bars, 50 µm. (C) Tukey boxplots showing quantified axonal density, nuclear density, 
protein:lipid ratio, and classifier values for all FOVs taken from the necrotic tumor core, viable 
tumor edge, and at 5-mm increments from 5-30 mm from the gross tumor margin (n = 8). Outlier 
cutoff defined as median ±1.5 interquartile range. 
 
Table 1. Quantitative comparison of H&E histology and SRS microscopy. Three 
neuropathologists (R1, R2, and R3) reviewed a series of 75 H&E stained tissues and 75 matched 
SRS FOVs and rated the degree of tumor infiltration via web-based survey. The category 
indicated as “normal” in the table represents FOVs categorized as normal to minimally 
hypercellular tissue with scattered atypical cells. 
 
 
Diagnosis 
 
 
Modality 
Neuropathologist 
R1 
Neuropathologist 
R2 
Neuropathologist 
R3 
Overall 
accuracy 
(%) Correct Incorrect Correct Incorrect Correct Incorrect 
Normal H&E 25 0 25 0 24 1 98.7 SRS 24 1 25 0 25 0 98.7 
Infiltrating 
glioma 
H&E 14 11 23 2 25 0 82.7 
SRS 25 0 18 7 24 1 89.3 
High-density 
glioma 
H&E 22 3 25 0 25 0 96.0 
SRS 25 0 25 0 23 2 97.3 
Totals 
H&E 61 14 73 2 74 1 92.4 
SRS 74 1 68 7 72 3 95.1 
Both 135 15 141 9 146 4 93.8 
Table 2. Evaluation of classifiers as indicators of tumor infiltration. Nuclear density, 
axonal density, and protein:lipid ratio were measured for each of the 1477 300x300 µm2 
FOVs from 51 fresh tissue biopsies from 18 patients. A quasi-likelihood approach with a 
GAM was used to incorporate all of the attributes into a single classifier. Half of the FOVs 
(n=738) were used to create the classifier, which was then tested on the other half of the data 
(n=739). Given that glioma can be more difficult to distinguish from normal tissue than 
metastases and extra-axial tumors, a quasi-likelihood generalized additive model (GAM) was 
also used on a subset of tumors, excluding all non-glial tumors, to create the glioma-only 
classifier. To eliminate correlation between the testing set and training set, we used a leave-
one-out cross-validation approach. The leave-one-out cross-validation was performed in a 
data set excluding non-glioma patients. CI, confidence interval. 
Classification condition Area 
under 
curve 
Mean 
sensitivity 
(%) 
95% CI Mean 
specificity 
(%) 
95% CI 
GAM (all subjects)      
Normal vs. abnormal 0.995 97.5 95.9-98.9 98.5 97.0-99.7 
Normal vs. infiltrating 0.988 94.7 91.4-98.9 98.5 97.0-99.5 
Normal vs. dense 0.989 98.0 95.6-100 99.0 97.4-100 
GAM (glioma only)      
Normal vs. abnormal 0.994 97.0 95.0-98.7 98.7 97.2-99.5 
Normal vs. infiltrating 0.988 94.9 91.3-98.1 98.5 97.1-99.5 
Normal vs. dense 0.990 98.2 95.1-100 99.0 98.2-100 
Leave-one-out cross-validation     
Normal vs. abnormal 0.893 87.3 n/a 87.5 n/a 
Normal vs. infiltrating 0.911 82.8 n/a 95 n/a 
Normal vs. dense 0.908 83.9 n/a 93.3 n/a 
 
